Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
30.0%
% of XPH's 40 holdings also in PPH
50.0%
% of PPH's 27 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.1% | 6.2% | 5.1% |
|
ELI LILLY & CO | 4.8% | 11.7% | 4.8% |
|
PFIZER INC | 4.9% | 4.7% | 4.7% |
|
JOHNSON & JOHNSON | 4.5% | 6.4% | 4.5% |
|
ZOETIS INC | 4.5% | 4.2% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PPH
|
AXSOME THERAPEUTICS, INC. | 4.7% |
|
ORGANON & CO. | 4.7% |
|
INTRA-CELLULAR THERAPIES INC | 4.6% |
|
ROYALTY PHARMA PLC CLASS A | 4.4% |
 |
PERRIGO CO | 4.2% |
|
CORCEPT THERAPEUTICS INC | 4.0% |
|
ELANCO ANIMAL HEALTH, INC. | 4.0% |
|
CATALENT INC | 3.8% |
|
JAZZ PHARMACEUTICALS PLC | 3.5% |
|
VIATRIS, INC. | 2.6% |
XPH Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -9.6% |
|
ELI LILLY & CO | -6.9% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.9% |
|
ABBVIE INC | -5.4% |
 |
NOVARTIS AG-ADR | -5.0% |
|
MCKESSON CORP | -4.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.8% |
 |
SANOFI-AVENTIS-ADR | -4.7% |
|
AMERISOURCEBERGEN CORP | -4.3% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.1% |